Global Downstream Processing Market

Downstream Processing Market Size, Share, Growth Analysis, By Product(Chromatography columns and resins, filters, membrane adsorbers, single use products), By Technique(Purification techniques (gel chromatography, ion exchange chromatography, affinity chromatography, hydrophobic interaction chromatography)), By Application(Monoclonal antibody production, vaccines production, insulin production, immunoglobulin production), By End User(Biopharmaceutical Manufacturers, and Contract Manufacturing Organizations), By Region - Industry Forecast 2024-2031

Report ID: SQMIG35H2109 | Region: Global | Published Date: March, 2024
Pages: 219 | Tables: 67 | Figures: 77

Downstream Processing Market News

  • In March 2024, MilliporeSigma announced a strategic partnership with Lotte to equip a former Bristol Myers Squibb (BMS) plant.

  • In March 2024, MilliporeSigma made a substantial advancement in enhancing manufacturing flexibility and productivity by introducing the EX-CELL® Advanced™ HD Perfusion Medium. This creative off-the-shelf cell culture media is designed to support perfusion processes, enabling high productivity even at low perfusion rates. This enhancement aims to boost production yield and accelerate the speed of clinical development.

  • In February 2024, BASF SE, based in Ludwigshafen, Germany, officially commenced the divestment process for its shares in two joint venture companies: BASF Markor Chemical Manufacturing (Xinjiang) Co, Ltd and Markor Meiou Chemical (Xinjiang) Co, Ltd, located in Korla, China. This decision formulated in late 2023 is by BASF's worldwide methodology regarding 1,4-butanediol (BDO), a key chemical in its portfolio.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Downstream Processing Market size was valued at USD 30.98 Billion in 2022 and is poised to grow from USD 35.69 Billion in 2023 to USD 110.79 Billion by 2031, at a CAGR of 15.21% during the forecast period (2024-2031).

These companies compete based on factors such as product portfolio, technological advancements, pricing strategies, customer relationships, and global presence. They strive to differentiate themselves by offering innovative solutions, providing excellent customer support, and continuously improving their offerings to meet the evolving demands of the biopharmaceutical industry. 'Thermo Fisher Scientific Inc. (United States)', 'GE Healthcare (United States)', 'Merck KGaA (Germany)', 'Sartorius AG (Germany)', 'Danaher Corporation (United States)', '3M Company (United States)', 'MilliporeSigma (United States)', 'Novasep Holding S.A.S. (France)', 'Lonza Group Ltd. (Switzerland)', 'Eppendorf AG (Germany)', 'Repligen Corporation (United States)', 'Charles River Laboratories International, Inc. (United States)', 'Boehringer Ingelheim International GmbH (Germany)', 'Avantor, Inc. (United States)', 'Corning Incorporated (United States)', 'Pall Corporation (United States)', 'Shimadzu Corporation (Japan)', 'Agilent Technologies, Inc. (United States)', 'ABEC, Inc. (United States)', 'Nova Biomedical (United States)', 'JSR Corporation (Japan)', 'NIZO (Netherlands)'

The demand for biopharmaceuticals, such as monoclonal antibodies, vaccines, and recombinant proteins, has been steadily rising. Downstream processing plays a crucial role in purifying and isolating these complex biological products, ensuring their safety and efficacy. As the biopharmaceutical industry expands, the demand for downstream processing technologies and equipment grows. 

Process Intensification and Continuous Manufacturing: Process intensification involves optimizing downstream processing operations to achieve higher productivity, improved yield, and reduced processing times. Continuous manufacturing approaches, such as continuous chromatography and continuous centrifugation, are gaining prominence as they enable real-time monitoring, process control, and enhanced process efficiency. These trends aim to streamline and shorten the overall downstream processing timeline, leading to increased productivity and cost savings. 

Due to government assistance for developing bioprocess technologies, rising medical costs, and an established healthcare infrastructure, North America held a lion's share of the downstream processing market in 2022 with a revenue share of 34.57%. Growth in the USA market is due to rising production and consumption of biopharmaceutic also, government support, the surge in chronic and infectious diseases. The manufacturers focuses on expanding their manufacturing facility and product portfolio and found new avenues for research. Additionally, major firms in the downstream processing market are growing their presence in this area. 

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Event Stream Processing Market
Buy Now GET FREE SAMPLE
Pipeline Transportation Market
Buy Now GET FREE SAMPLE
Connected Logistics Market
Buy Now GET FREE SAMPLE
Business Process Outsourcing Market
Buy Now GET FREE SAMPLE
Pipeline Monitoring Systems Market
Buy Now GET FREE SAMPLE
Tangential Flow Filtration Market
Buy Now GET FREE SAMPLE
Single Use Bioprocessing Market
Buy Now GET FREE SAMPLE
Pipeline Integrity Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Downstream Processing Market

Report ID: SQMIG35H2109

$5,300
BUY NOW GET FREE SAMPLE